Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Edward J III Dulac Insider Profile
4 Followers
Edward J III Dulac, CFO at Fate Therapeutics, holds 66.32K shares in Intellia Therapeutics (Ticker: NTLA), holds 101.48K shares in Fate Therapeutics (Ticker: FATE).
Profitable Transactions
5 out of 6 Profitable Transactions
Average Return
+42.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Edward J III Dulac holds in companies
Most Profitable Insider Trade
The most profitable trade made by Edward J III Dulac
Edward J III Dulac's Trading History
Fate Therapeutics
Mar 05, 2024
CFO
Uninformative Sell
19.01K
$389.68K
Intellia Therapeutics
Jul 24, 2024
EVP, Chief Financial Officer
Uninformative Buy
―
$1.57M
List of latest transactions for each holding click on a transaction to see Edward J III Dulac's performance on stock
You May Also Like
Edward J III Dulac insider profile FAQ
What is the percentage of profitable transactions made by Edward J III Dulac?
The percentage of profitable transactions made by Edward J III Dulac is 83%.
What is the average return per transaction made by Edward J III Dulac?
The average return per transaction made by Edward J III Dulac is 42.90%.
What stocks does Edward J III Dulac hold?
Edward J III Dulac holds: FATE, NTLA stocks.
What was Edward J III Dulac’s latest transaction?
Edward J III Dulac latest transaction was an Uninformative Buy of ―.
What was Edward J III Dulac's most profitable transaction?
Edward J III Dulac’s most profitable transaction was an Informative Sell of FATE stock on August 19, 2022. The return on the trade was 90.40%.
What is Edward J III Dulac's role in Fate Therapeutics?
Edward J III Dulac's role in Fate Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.